Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 06:36 ET | Source: Research and Markets

Chronic Obstructive Pulmonary Disease (COPD) Market Trends, Size, Shares, Competition, SWOT Analysis and Growth Forecast 2025-2033

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD) Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ...
October 23, 2025 05:38 ET | Source: Research and Markets

United States Chronic Obstructive Pulmonary Disease Market Report 2025-2033, Profiles of AstraZeneca, Pfizer, GSK, Novartis, Astellas Pharma, Abbott Laboratories, Boehringer Ingelheim, Almirall

Dublin, Oct. 23, 2025 (GLOBE NEWSWIRE) -- The "United States Chronic Obstructive Pulmonary Disease (COPD) Market Report by Type, Treatment, Distribution Channels, States and Company Analysis,...
September 10, 2024 05:12 ET | Source: Research and Markets

Chronic Obstructive Pulmonary Disease (COPD) Market Forecast Report and Company Analysis 2024-2032 Featuring AstraZeneca, Pfizer, GSK, Novartis, Astellas, Abbott, Boehringer Ingelheim, Almirall

Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease, Market Report, Forecast by Types, Treatment Types, Distribution Channels, Countries and Company Analysis,...
July 17, 2024 09:07 ET | Source: Research and Markets

Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Report 2024: Comprehensive Insights About 65+ Companies and 70+ Pipeline Drugs

Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report...
April 05, 2023 04:33 ET | Source: Research and Markets

Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2023: Over 65 Companies Developing Drugs for COPD with Several in Phase III of Testing

Dublin, April 05, 2023 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.This report...
March 22, 2023 12:30 ET | Source: SPHERICAL INSIGHTS LLP

Global Chronic Obstructive Pulmonary Disease Market Size To Grow USD 35.9 Billion By 2030 | CAGR of 8.2%

New York, United States, March 22, 2023 (GLOBE NEWSWIRE) -- The Global Chronic Obstructive Pulmonary Disease Market Size to grow from USD 18.20 billion in 2021 to USD 35.90 billion by 2030, at a...
February 23, 2023 07:58 ET | Source: Research and Markets

Anti-Asthmatics And COPD Drugs Global Market Report 2023: A $117.36 Billion Market by 2027 Featuring Novartis, Merck, GSK, Boehringer Ingelheim, AstraZeneca, Roche, Teva, Vectura, Pfizer and Abbott

Dublin, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The "Anti-Asthmatics And COPD Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.Major players in the...
January 23, 2023 10:03 ET | Source: Research and Markets

Global Chronic Obstructive Pulmonary Disease (COPD) Market Report 2023 - 2028: Featuring AstraZeneca, Pfizer, GlazoSmithKline and Novartis Among Others

Dublin, Jan. 23, 2023 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD) Market, Global Forecast 2023-2028, Industry Trends, Growth, Insight, Impact of Inflation, Company...
May 14, 2021 08:08 ET | Source: Research and Markets

Global Chronic Obstructive Pulmonary Disease Markets, Epidemiology and Patient Flow Report 2020-2035: Focus on US, Germany, France, Italy, Spain, UK, Japan, G7 Countries

Dublin, May 14, 2021 (GLOBE NEWSWIRE) -- The "Global Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering. Global...